4basebio PLC (88Q.DE)

EUR 14.6

(0.0%)

Operating Expenses Summary of 4basebio PLC

  • 4basebio PLC's latest annual operating expenses in 2023 was 8.39 Million GBP , up 39.92% from previous year.
  • 4basebio PLC's latest quarterly operating expenses in 2024 Q2 was 5.16 Million EUR , down 0.0% from previous quarter.
  • 4basebio PLC reported a annual operating expenses of 6.07 Million GBP in annual operating expenses 2022, up 60.14% from previous year.
  • 4basebio PLC reported a annual operating expenses of 3.79 Million GBP in annual operating expenses 2021, up 323.66% from previous year.
  • 4basebio PLC reported a quarterly operating expenses of 4.11 Million EUR for 2023 Q4, up 13.58% from previous quarter.
  • 4basebio PLC reported a quarterly operating expenses of 8.5 Million GBP for 2023 FY, up 39.92% from previous quarter.

Annual Operating Expenses Chart of 4basebio PLC (2023 - 2019)

Historical Annual Operating Expenses of 4basebio PLC (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 8.39 Million GBP 39.92%
2022 6.07 Million GBP 60.14%
2021 3.79 Million GBP 323.66%
2020 896 Thousand GBP 128.57%
2019 392 Thousand GBP 0.0%

Peer Operating Expenses Comparison of 4basebio PLC

Name Operating Expenses Operating Expenses Difference
BioNTech SE 2.52 Billion EUR 99.668%
CureVac N.V. 211.75 Million EUR 96.037%
Biotest Aktiengesellschaft 136.8 Million EUR 93.865%
Biotest Aktiengesellschaft 136.8 Million EUR 93.865%
BRAIN Biotech AG 24.94 Million EUR 66.353%
Formycon AG 23.73 Million EUR 64.64%
Heidelberg Pharma AG 27.81 Million EUR 69.83%
Medigene AG 20.54 Million EUR 59.143%